[1] Zeng MS,Ye HY,Guo L,et al. Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients: a multicenter,open-label,phase Ⅲ study. Hepatobiliary Pancreat Dis Int. 2013, 12:607-616.
[2] 中华医学会放射学分会腹部学组.肝胆特异性MRI对比剂钆塞酸二钠临床应用专家共识. 中华放射学杂志.2016, 50:641-645.
[3] 中华人民共和国卫生部. 原发性肝癌诊疗规范(2011年版). 临床肿瘤学杂志. 2011, 16:929-946.
[4] 丁可,刘满荣,杨新官,等. 乏血供型肝细胞癌的CT诊断. 实用放射学杂志. 2012,28:469-472.
[5] Kitao A,Matsui O,Yoneda N,et al. Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images. Radiology. 2012, 265:780-789.
[6] Narita M, Hatano E, Arizono S, et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol. 2009, 44:793-798.
[7] 田园,刘鹏飞,孙鹏,等. 钆塞酸二钠MR增强延迟期对肝脏局灶性病变的诊断价值. 哈尔滨医科大学学报. 2016, 50:337-341.
[8] 李秀丽,吴秀蓉. 混合型肝癌的CT和MRI表现. 中华放射学杂志. 2012, 46:701-704. |
